INTERVIEW ON THE PRICE OF BUSINESS SHOW, MEDIA PARTNER OF THIS SITE. Recently Kevin Price, Host of the nationally syndicated Price of Business Show, interviewed Paul Brennan. Paul Brennan, President & CEO, NervGen Pharma, discusses how his company’s lead product – NVG-291 – is being developed for spinal cord injury, multiple sclerosis and Alzheimer’s disease. LISTEN TO THE INTERVIEW…
